Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1918 1
1919 2
1925 1
1945 1
1947 1
1948 1
1949 3
1967 1
1968 2
1969 1
1970 1
1983 1
1984 1
1985 1
1986 1
1987 2
1988 5
1989 1
1993 1
1995 3
1996 1
2000 1
2001 1
2002 2
2004 2
2005 1
2010 1
2011 5
2012 3
2013 3
2014 3
2015 1
2016 4
2017 4
2018 3
2019 3
2020 2
2021 5
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer.
Gonzalvez F, Vincent S, Baker TE, Gould AE, Li S, Wardwell SD, Nadworny S, Ning Y, Zhang S, Huang WS, Hu Y, Li F, Greenfield MT, Zech SG, Das B, Narasimhan NI, Clackson T, Dalgarno D, Shakespeare WC, Fitzgerald M, Chouitar J, Griffin RJ, Liu S, Wong KK, Zhu X, Rivera VM. Gonzalvez F, et al. Among authors: narasimhan ni. Cancer Discov. 2021 Jul;11(7):1672-1687. doi: 10.1158/2159-8290.CD-20-1683. Epub 2021 Feb 25. Cancer Discov. 2021. PMID: 33632773
Artificial limbs.
NARASIMHAN NS. NARASIMHAN NS. Antiseptic. 1947 Feb;44(2):65-76. Antiseptic. 1947. PMID: 20288183 No abstract available.
Effect of severe renal impairment on the pharmacokinetics of brigatinib.
Gupta N, Hanley MJ, Kerstein D, Tugnait M, Narasimhan N, Marbury TC, Venkatakrishnan K. Gupta N, et al. Among authors: narasimhan n. Invest New Drugs. 2021 Oct;39(5):1306-1314. doi: 10.1007/s10637-021-01095-5. Epub 2021 Mar 20. Invest New Drugs. 2021. PMID: 33742299 Free PMC article. Clinical Trial.
Leishmania Sores and Antimony.
Narasimhan NS. Narasimhan NS. Ind Med Gaz. 1918 Oct;53(10):396. Ind Med Gaz. 1918. PMID: 29006756 Free PMC article. No abstract available.
Brigatinib pharmacokinetics in patients with chronic hepatic impairment.
Hanley MJ, Kerstein D, Tugnait M, Narasimhan N, Marbury TC, Venkatakrishnan K, Gupta N. Hanley MJ, et al. Among authors: narasimhan n. Invest New Drugs. 2023 Jun;41(3):402-410. doi: 10.1007/s10637-023-01339-6. Epub 2023 Apr 13. Invest New Drugs. 2023. PMID: 37052729 Free PMC article.
Clinical Cases.
Narasimhan NS. Narasimhan NS. Ind Med Gaz. 1919 Nov;54(11):417-418. Ind Med Gaz. 1919. PMID: 29006625 Free PMC article. No abstract available.
Ponatinib in refractory Philadelphia chromosome-positive leukemias.
Cortes JE, Kantarjian H, Shah NP, Bixby D, Mauro MJ, Flinn I, O'Hare T, Hu S, Narasimhan NI, Rivera VM, Clackson T, Turner CD, Haluska FG, Druker BJ, Deininger MW, Talpaz M. Cortes JE, et al. Among authors: narasimhan ni. N Engl J Med. 2012 Nov 29;367(22):2075-88. doi: 10.1056/NEJMoa1205127. N Engl J Med. 2012. PMID: 23190221 Free PMC article. Clinical Trial.
75 results